Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

2017

Half-year report 31 December 2016

24 February 2017 by Audrey Thomson

Half-year report 31 December 2016

Categories 2017, ASX Announcements, Half-year reports

R&D Tax Incentive

13 February 2017 by Audrey Thomson

R&D Tax Incentive

Categories 2017, ASX Announcements

Commencement of BIT225 Phase 2 HIV-1 Clinical Trial

13 February 2017 by Audrey Thomson

Commencement of BIT225 Phase 2 HIV-1 Clinical Trial

Categories 2017, ASX Announcements

BIT225 Accelerates HIV-1 Virus Reduction

6 February 2017 by Karen Mobbs

BIT225 Accelerates HIV-1 Virus Reduction

Categories 2017, ASX Announcements

Appendix 4C

16 January 2017 by Audrey Thomson

Appendix 4C

Categories 2017, ASX Announcements

Biotron Limited Presents at Biotech Showcase 2017

13 January 201713 January 2017 by Audrey Thomson

Biotron Limited Presents at Biotech Showcase 2017

Categories 2017, ASX Announcements
Newer posts
← Previous Page1 … Page3 Page4
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 12 December 2025        Legal Notices and Privacy
Cleantalk Pixel